Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Framingham, MA
SEC filing record 1 source field available
Fiscal year end
30 September
Arch Therapeutics, Inc. has filed 558 SEC EDGAR filings since 05 Jan 2012

SEC filing history

Showing 526-550 of 558 matching filings.

Per page
25
Current page
22
3

OWNERSHIP DOCUMENT

Filing date
12 Jul 2013
Reporting date
08 Jul 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-87522

SC 13D

Filing date
08 Jul 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54986

8-K

Filing date
08 Jul 2013
Reporting date
08 Jul 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-87522

SC 13D

Filing date
08 Jul 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-199126

D filing

Filing date
08 Jul 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
26 Jun 2013
Reporting date
26 Jun 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
26 Jun 2013
Reporting date
26 Jun 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
26 Jun 2013
Reporting date
26 Jun 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
26 Jun 2013
Reporting date
26 Jun 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
26 Jun 2013
Reporting date
26 Jun 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
26 Jun 2013
Reporting date
26 Jun 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-A12G File 000-54986

8-A12G

Filing date
26 Jun 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 333-178883

FORM 8-K

Filing date
26 Jun 2013
Reporting date
25 Jun 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 333-178883

8-K CURRENT REPORT

Filing date
24 Jun 2013
Reporting date
18 Jun 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 333-178883

8-K

Filing date
05 Jun 2013
Reporting date
05 Jun 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 333-178883

FORM 8-K

Filing date
24 May 2013
Reporting date
24 May 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 333-178883

NT 10-Q

Filing date
15 May 2013
Reporting date
31 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 333-178883

FORM 8-K

Filing date
13 May 2013
Reporting date
10 May 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 333-178883

8-K

Filing date
29 Apr 2013
Reporting date
23 Apr 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 333-178883

FORM 8-K

Filing date
25 Apr 2013
Reporting date
19 Apr 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 333-178883

10-Q filing

Filing date
14 Feb 2013
Reporting date
31 Dec 2012
Next action
Verify source filing
10-K File 333-178883

10-K filing

Filing date
31 Dec 2012
Reporting date
30 Sep 2012
Next action
Verify source filing
10-Q File 333-178883

10-Q filing

Filing date
14 Aug 2012
Reporting date
30 Jun 2012
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .